4//SEC Filing
GOLDSMITH MARK A 4
Accession 0001610717-25-000423
CIK 0001628171other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:17 PM ET
Size
7.2 KB
Accession
0001610717-25-000423
Insider Transaction Report
Form 4
GOLDSMITH MARK A
DirectorSee Remarks
Transactions
- Sale
Common Stock
2025-12-16$76.82/sh−15,394$1,182,526→ 232,469 total
Holdings
- 67,424(indirect: By Trust)
Common Stock
- 67,424(indirect: By Trust)
Common Stock
- 570,050(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 168,763 restricted stock units.
- [F3]Held by Jonathan Goldsmith Revocable Trust.
- [F4]Held by Rebecca Goldsmith Revocable Trust.
- [F5]Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001246842
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:17 PM ET
- Size
- 7.2 KB